Islamic republic of Iran and Its Opposition [PDF]
This paper takes a stylized paradoxical fact of Iranian politics under the Islamic Republic of Iran as its starting point: the stark confusion between the position and a good portion of the opposition.
Mehrdad Vahabi, Mohajer Nasser
core
The Correlation Between Temperament and Fitness for Work According to the Persian Medicine Viewpoints. [PDF]
Mazhari MM +4 more
europepmc +1 more source
Perception of Spatial Legibility and Its Association with Human Mobility Patterns: An Empirical Assessment of the Historical Districts in Rasht, Iran. [PDF]
Askarizad R, He J.
europepmc +1 more source
This study examines the feminisation of dīv figures in Qajar visual culture (c. 1789–1925) and its relation to gendered representations and secularising discourses.
Nahid Jafari Dehkordi
doaj
New Documents about Lady Kahhal, First Female Ophthalmologist in Iran. [PDF]
Golshani SA, Daneshfard B.
europepmc +1 more source
"FARANG" in Qajar Historians` Narration
هم سرنوشت بودن داستان و تاریخ، معمای غامضی نیست.زیرا اندکی دقت در مفهوم واژه تاریخ میتواند چارهساز باشد.بیگمان این نکته پذیرفتنی است که جهان تشکیل شده از رویدادهای بسیار است.اما میان رویدادهای معطوف و رویدادهای به شمار نیامده، تفاوت بسیار است.تاریخ به معنای پژوهش درباره رویدادهایی است که در یک دوره زمانی خاص از سوی افراد پژوهشگر به شمار آمده، به ...
openaire +1 more source
The impact of archaism discourse on Iranian medical historiography from the Achaemenid period. [PDF]
Kasiri M.
europepmc +1 more source
Crystal structures and Hirshfeld surface analyses of (E)-1-[1-(4-tert-butyl-phen-yl)-2,2-di-chloro-ethen-yl]-2-phenyl-diazene, (E)-1-[1-(4-tert-butyl-phen-yl)-2,2-di-chloro-ethen-yl]-2-(4-methyl-phen-yl)diazene, (E)-1-[1-(4-tert-butyl-phen-yl)-2,2-di-chloro-ethen-yl]-2-(4-meth-oxy-phen-yl)diazene and (E)-1-[1-(4-tert-butyl-phen-yl)-2,2-di-chloro-ethen-yl]-2-(3-methyl-phen-yl)diazene. [PDF]
Maharramov A +8 more
europepmc +1 more source
Scarlet Fever in Iran During the Qajar Period (1796 to 1925 AD); A Brief Historical Review. [PDF]
Golshani SA, Mansourbakht G, Haghighi M.
europepmc +1 more source

